Your browser doesn't support javascript.
loading
Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic Features.
Parikh, Rahul A; Appleman, Leonard J; Beumer, Jan H; Matczak, Ewa; Chu, Edward.
Afiliação
  • Parikh RA; Division of Hematology-Oncology, University of Pittsburgh School of Medicine, Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA.
  • Appleman LJ; Division of Hematology-Oncology, University of Pittsburgh School of Medicine, Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA. Electronic address: applemanlj@upmc.edu.
  • Beumer JH; University of Pittsburgh School of Pharmacy, Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA.
  • Matczak E; Pfizer Oncology, New York, NY.
  • Chu E; Division of Hematology-Oncology, University of Pittsburgh School of Medicine, Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA.
Clin Genitourin Cancer ; 15(1): 7-22, 2017 02.
Article em En | MEDLINE | ID: mdl-27473523

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Inibidores de Proteínas Quinases / Serina-Treonina Quinases TOR / Neoplasias Renais Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Inibidores de Proteínas Quinases / Serina-Treonina Quinases TOR / Neoplasias Renais Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article